(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 5.39%
Live Chart Being Loaded With Signals
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally...
Stats | |
---|---|
今日成交量 | 2 529.00 |
平均成交量 | 8 212.00 |
市值 | 37.33M |
EPS | $0 ( 2024-03-22 ) |
下一个收益日期 | ( $0 ) 2024-05-09 |
Last Dividend | $0.100 ( 2023-07-25 ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.51 |
ATR14 | $0.0980 (1.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Kolinski Catherine | Buy | 0 | |
2023-06-09 | Vigilante Donna | Sell | 0 | United-Guardian,Inc. Common Stock |
2022-11-01 | Blanco Beatriz | Buy | 0 | |
2022-11-01 | Blanco Beatriz | Buy | 0 | |
2021-02-19 | Globus Kenneth H | Sell | 8 400 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 97 transactions |
Buy: 1 400 | Sell: 81 010 |
United-Guardian Inc 财务报表
Annual | 2023 |
营收: | $10.89M |
毛利润: | $5.41M (49.66 %) |
EPS: | $0.560 |
FY | 2023 |
营收: | $10.89M |
毛利润: | $5.41M (49.66 %) |
EPS: | $0.560 |
FY | 2022 |
营收: | $12.70M |
毛利润: | $6.70M (52.78 %) |
EPS: | $0.560 |
FY | 2021 |
营收: | $13.93M |
毛利润: | $8.18M (58.74 %) |
EPS: | $1.010 |
Financial Reports:
No articles found.
United-Guardian Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.310 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.100 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0600 | 1997-12-10 |
Last Dividend | $0.100 | 2023-07-25 |
Next Dividend | $0 | N/A |
Payout Date | 2023-08-02 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | $15.69 | -- |
Avg. Dividend % Per Year | 2.37% | -- |
Score | 5.22 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.39 | |
Div. Directional Score | 9.37 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.0600 | 3.43% |
1998 | $0.0180 | 0.44% |
1999 | $0.0180 | 0.42% |
2000 | $0.100 | 2.67% |
2001 | $0.100 | 2.22% |
2002 | $0.100 | 1.92% |
2003 | $0.150 | 3.64% |
2004 | $0.430 | 5.48% |
2005 | $0.470 | 5.60% |
2006 | $0.470 | 5.25% |
2007 | $0.550 | 6.43% |
2008 | $0.550 | 5.24% |
2009 | $0.600 | 6.64% |
2010 | $0.630 | 5.48% |
2011 | $0.800 | 5.59% |
2012 | $1.360 | 9.07% |
2013 | $0.970 | 4.85% |
2014 | $0.800 | 2.86% |
2015 | $1.000 | 5.14% |
2016 | $0.750 | 3.69% |
2017 | $0.920 | 5.95% |
2018 | $1.050 | 5.79% |
2019 | $1.100 | 5.84% |
2020 | $0.780 | 3.84% |
2021 | $1.130 | 7.77% |
2022 | $0.680 | 4.12% |
2023 | $0.100 | 0.94% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.237 | 1.500 | 5.26 | 7.89 | [0 - 0.5] |
returnOnAssetsTTM | 0.193 | 1.200 | 3.56 | 4.27 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.178 | -1.000 | 8.22 | -8.22 | [0 - 1] |
currentRatioTTM | 7.99 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.95 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 5.37 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00159 | -1.500 | 9.97 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -23.79 | 1.000 | -9.92 | -9.92 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.684 | 2.00 | 9.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.648 | 2.00 | 9.68 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00187 | -1.500 | 9.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.497 | 1.000 | 5.06 | 5.06 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.263 | 1.000 | 6.74 | 6.74 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 147.87 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.815 | 0.800 | 7.90 | 6.32 | [0.5 - 2] |
Total Score | 11.36 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.46 | 1.000 | 8.64 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.648 | 2.00 | 9.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.31 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.684 | 2.00 | 9.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.178 | 1.500 | 8.22 | -8.22 | [0 - 1] |
pegRatioTTM | 3.83 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.289 | 1.000 | 5.28 | 0 | [0.1 - 0.5] |
Total Score | 7.39 |
United-Guardian Inc
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。